MENU
+Compare
THTX
Stock ticker: NASDAQ
AS OF
Apr 10, 04:59 PM (EDT)
Price
$1.33
Change
-$0.09 (-6.34%)
Capitalization
59.67M

THTX Theratechnologies Forecast, Technical & Fundamental Analysis

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients... Show more

THTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for THTX with price predictions
Apr 09, 2025

THTX's RSI Oscillator recovers from overbought zone

The 10-day RSI Oscillator for THTX moved out of overbought territory on March 27, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 25 instances where the indicator moved out of the overbought zone. In of the 25 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on April 09, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on THTX as a result. In of 115 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for THTX turned negative on April 09, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at .

THTX moved below its 50-day moving average on April 08, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for THTX crossed bearishly below the 50-day moving average on March 05, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where THTX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

THTX broke above its upper Bollinger Band on March 26, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for THTX entered a downward trend on March 20, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 59 cases where THTX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where THTX advanced for three days, in of 219 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. THTX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (13.320). P/E Ratio (0.000) is within average values for comparable stocks, (62.790). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.760). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (0.762) is also within normal values, averaging (246.160).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. THTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
THTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

THTX is expected to report earnings to fall 30.00% to -7 cents per share on October 11

Theratechnologies THTX Stock Earnings Reports
Q3'23
Est.
$-0.07
Q2'23
Missed
by $0.04
Q1'23
Missed
by $0.06
Q4'22
Missed
by $0.01
Q3'22
Est.
$-0.08
The last earnings report on July 12 showed earnings per share of -10 cents, missing the estimate of -5 cents. With 185.63K shares outstanding, the current market capitalization sits at 59.67M.
A.I. Advisor
published General Information

General Information

a pharmaceutical company, which engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV)

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2015, rue Peel
Phone
+1 514 336-7800
Employees
58
Web
https://www.theratech.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EBON3.550.38
+11.85%
Ebang International Holdings
GMED74.285.64
+8.22%
Globus Medical
ACN299.9418.55
+6.59%
Accenture PLC
AROW25.371.21
+5.01%
Arrow Financial Corp
CXW20.380.88
+4.51%
CoreCivic

THTX and Stocks

Correlation & Price change

A.I.dvisor tells us that THTX and IDYA have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that THTX and IDYA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To THTX
1D Price
Change %
THTX100%
-9.10%
IDYA - THTX
27%
Poorly correlated
+8.69%
GNPX - THTX
27%
Poorly correlated
+8.06%
CSLLY - THTX
26%
Poorly correlated
+6.37%
BEAM - THTX
25%
Poorly correlated
+12.59%
GLTO - THTX
24%
Poorly correlated
+8.93%
More